|
|
||||||||


* Department of Pathology and Experimental Medicine, Graduate School of Medical Sciences, School of Medicine, Kumamoto University, Kumamoto, Japan;
Department of Molecular Genetics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan; and
Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan
| Abstract |
|---|
|
|
|---|
, MIP-2, KC chemokine (KC), and MCP-1/CCL2. Stat3 was tyrosine phosphorylated in peritoneal resident macrophages as well as infiltrating leukocytes in the littermate controls, suggesting that Stat3 in either or both of these cells might play a regulatory role in inflammation. The peritoneal levels of TNF-
, MIP-2, KC, and MCP-1 were similarly elevated in LysMcre/Stat3flox/ mice rendered leukopenic by cyclophosphamide treatment as compared with the controls. Adoptive transfer of resident macrophages from LysMcre/Stat3flox/ mice into the control littermates resulted in increases in the peritoneal level of TNF-
, MIP-2, KC, and MCP-1 after i.p. injection of thioglycollate. Under these conditions, control littermates harboring LysMcre/Stat3flox/ macrophages exhibited an augmented leukocyte infiltration relative to those received control macrophages. Taken together, these data provide evidence that resident macrophages, but not other cell types, play a regulatory role in inflammation through a Stat3 signaling pathway. Stat3 in resident macrophages appears to function as a repressor protein in this model of acute inflammation. | Introduction |
|---|
|
|
|---|
Stat proteins are transcription factors that mediate cytokine signaling and are implicated in a variety of immune responses (5). We have demonstrated in a murine model of septic peritonitis that mice deficient in Stat4 and Stat6 are resistant to the lethality by balancing local type 1 and systemic type 2 cytokine responses (6), thereby providing clear evidence that Stat proteins are important in innate immunity. Recently, we have shown that mice with targeted disruption of Stat3 gene in macrophages and neutrophils exhibit exaggerated cytokine production and increased lethality in a murine model of endotoxin shock and septic peritonitis (7, 8). Stat3 is a transcription factor mediating anti-inflammatory effects of IL-10 (8, 9). IL-10 ameliorates the inflammatory responses by inhibiting the production of inflammatory cytokines. Although IL-10 has diverse effects on multiple cell types (4), our previous data in septic peritonitis model indicate that Stat3 associated with macrophages and neutrophils is an important regulator of inflammation (7). This suggests that resident macrophages or/and infiltrating leukocytes (macrophages and neutrophils) may be responsible for the regulation through a Stat3 signaling pathway.
To further address the role of Stat3 in inflammation, we have extended our previous work and attempted to characterize the mechanisms whereby Stat3 is involved in inflammation. For this purpose, mice lacking Stat3 in macrophages and neutrophils were injected i.p. with thioglycollate, and the subsequent inflammatory responses were investigated. In this study, we provide evidence that the Stat3 signaling pathway in peritoneal resident macrophages, but not other cell types, functions as a down-regulator of inflammation in a murine peritonitis model. Resident macrophages trigger inflammation by producing an array of cytokines and chemokines, but the production of these mediators is negatively regulated in the cells through a Stat3 signaling pathway.
| Materials and Methods |
|---|
|
|
|---|
LysMcre/Stat3+/ mice and Stat3flox/+ mice were provided by Dr. S. Akira (Osaka University, Osaka, Japan). These mice were mated to generate LysMcre/Stat3flox/ mice, in which Stat3 was selectively disrupted in the myeloid cells (8). LysMcre/Stat3+/+ mice from these crosses were used as wild-type littermate controls in the experiments. Male mice (68 wk) were used in this study under specific pathogen-free conditions. The animal use committee at the Kumamoto University approved all studies.
Thioglycollate-induced peritonitis
Mice were injected i.p. with 1 ml of sterile 4% thioglycollate (Difco Laboratories). At different time points (0, 2, 4, 8, 24, and 48 h, 1012 mice each) after thioglycollate injection, mice were euthanized by cervical dislocation. Peritoneal lavages were collected by washing the peritoneum with 2 ml of sterile saline containing 5 mM EDTA, the lavages were centrifuged, and cell-free peritoneal fluids were stored at 20°C for measurements of cytokines/chemokines. Cell pellets were resuspended in saline, and the cell numbers were counted in a hemocytometer. Differential cell analysis was made after Diff-Quik staining of cytospin preparations.
Depletion of leukocytes
Peripheral leukocytes were depleted by i.p. injection of cyclophosphamide (150 mg/kg; Sigma-Aldrich) on days 3, 2, and 1 before thioglycollate injection (10). This resulted in peripheral blood leukopenia (<30 cells/µl) on days 0 and 1. Due to the leukopenia, the treatment effectively inhibited the thioglycollate-induced leukocyte infiltration as compared with saline-treated control (Table I).
|
Peritoneal lavages were collected from nontreated LysMcre/Stat3flox/ and LysMcre/Stat3+/+ mice as described above. Macrophages were positively purified with anti-mouse F4/80 Ag (Serotec) and anti-rat IgG microbeads using the MidiMACS system (Miltenyi Biotec) from the lavages. The purified cells were routinely >95% F4/80+ cells as assessed by flow cytometry (not shown). Four million resident peritoneal macrophages from LysMcre/Stat3flox/or LysMcre/Stat3+/+ mice were transferred into the peritoneum of nontreated LysMcre/Stat3+/+ mice. The transferred cell number was determined in reference to the number of resident peritoneal cells from nontreated mice. Two hours later, the mice were injected i.p. with 1 ml of sterile 4% thioglycollate, after which the mice were killed at 4 h, and the peritoneal lavages were collected as described above.
Western blotting
Leukocytes were dissolved in Laemmli buffer (1 x 106/50 µl), sonicated, boiled, fractionated on SDS-polyacrylamide gel (10 µl), and transferred to a nitrocellulose membrane. After blocking with TBS + 0.1% Tween 20 containing 5% skim milk for 1 h at room temperature, the membrane was incubated with Abs to Stat3 or tyrosine-phosphorylated Stat3 (Cell Signaling Technology) overnight at 4°C. After a washing with TBS + 0.1% Tween 20, the membrane was incubated with anti-HRP-linked Ab for 1 h at room temperature and visualized with an ECL system (Cell Signaling Technology).
Measurement of cytokines
Murine cytokines/chemokines were measured using a standard method of sandwich ELISA, as described (11, 12). The captured Abs, detection Abs, and the recombinant cytokines were purchased from R&D Systems. The ELISAs used in this study did not cross-react with other murine cytokines/chemokines available and constantly detected murine cytokines/chemokines above 10 pg/ml.
Statistics
Statistical significance was evaluated by an unpaired Student t test. p < 0.05 was regarded as statistically significant. All data were expressed as mean ± SE.
| Results |
|---|
|
|
|---|
To investigate the role of myeloid cell-associated Stat3 in acute inflammation, LysMcre/Stat3flox/ mice and the control littermates were injected with thioglycollate, after which the number of infiltrating leukocytes was counted. As shown in Fig. 1A, the neutrophil influx in control mice reached its peak at 4 h, and the level remained elevated by 48 h. In LysMcre/Stat3flox/ mice, the neutrophil infiltration also peaked at 4 h, but the level was significantly augmented, resulting in a 2.0-fold increase relative to the control. There were no differences in the number of neutrophils after 24 h between the groups (Fig. 1A). Likewise, the number of macrophages within 8 h, but not after 24 h, was augmented in LysMcre/Stat3flox/ mice, reaching a 1.5-fold increase at 4 h after the injection (Fig. 1B). Thus, leukocyte influx in mice lacking Stat3 in macrophages and neutrophils was augmented in an initial phase of inflammation (within 8 h).
|
Leukocyte infiltration is governed by multiple cytokines and chemokines (13). We next measured the peritoneal levels of several cytokines/chemokines known involved in inflammation in this model. The data in Fig. 2 demonstrated that levels of TNF-
, MIP-2, KC chemokine (KC),3 and MCP-1 in LysMcre/Stat3flox/ mice were significantly higher than those in the control littermates, resulting in a 4.1-, 1.6-, 2.5-, and 2.3-fold increase at their peak, respectively, relative to the control. IL-10 level peaked at 2 h in control mice, whereas the peak level persisted by 4 h in LysMcre/Stat3flox/ mice (Fig. 2). Interestingly, augmented levels of these cytokines/chemokines coincided well with the increased number of neutrophils and macrophages in LysMcre/Stat3flox/ mice. There is a direct link between cytokine/chemokine expression and the leukocyte infiltration in acute inflammation models (14, 15, 16). Thus, mice with Stat3 deficiency in macrophages and neutrophils demonstrated augmented production of cytokines/chemokines, accounting for the increases in the number of infiltrating leukocytes.
|
Experiments were next conducted to investigate whether Stat3 was activated in the peritoneal resident macrophages and the infiltrating leukocytes during inflammation. As shown in Fig. 3A, Stat3 in resident macrophages was tyrosine phosphorylated in control littermates, indicating that the Stat3 was spontaneously activated in the cells. The intensity of the phosphorylated Stat3 was increased at 4 h after the injection, suggesting that Stat3 activation was augmented during inflammation (Fig. 3A). In contrast, the phosphorylated Stat3 was completely abrogated in LysMcre/Stat3flox/ mice despite the negligible Stat3 protein in resident macrophages as well as infiltrating leukocytes (Fig. 3B). These results suggest that the augmented leukocyte infiltration in LysMcre/Stat3flox/ mice may be ascribed to the Stat3 in resident macrophages or/and infiltrating leukocytes composed of macrophages and neutrophils.
|
To examine whether Stat3 in the infiltrating leukocytes could be involved in the regulation of inflammation in this model, we compared the levels of TNF-
, MIP-2, KC, and MCP-1 in leukopenic mice, in which peripheral leukocytes were depleted with cyclophosphamide treatment. In leukopenic mice, the number of infiltrating leukocytes at 4 h after thioglycollate injection was significantly lower than that in saline-treated controls (Table I). As shown in Fig. 4, levels of TNF-
, MIP-2, KC, and MCP-1 in leukopenic LysMcre/Stat3flox/ mice were also increased as compared with leukopenic LysMcre/Stat3+/+ mice. There were no differences in the level of cytokines/chemokines between control and leukopenic LysMcre/Stat3flox/ mice (Fig. 4). It thus appears that Stat3 in the infiltrating leukocytes is not ascribed to the augmented productions of cytokines/chemokines.
|
We next asked whether Stat3 in the peritoneal resident macrophages could be responsible for the enhanced inflammatory response in LysMcre/Stat3flox/ mice. As shown in Table II, resident macrophages from LysMcre/Stat3flox/ mice produced significantly higher levels of TNF-
, MIP-2, KC, and MCP-1 relative to the control resident macrophages upon stimulation with thioglycollate in vitro. IL-10 level was also augmented in LysMcre/Stat3flox/ resident macrophages (Table II). When LysMcre/Stat3flox/ resident macrophages were transferred into LysMcre/Stat3+/+ mice, the mice demonstrated significant increases in the peritoneal levels of TNF-
, MIP-2, KC, and MCP-1, relative to the mice received the same number of LysMcre/Stat3+/+ resident macrophages, at 4 h after thioglycollate injection (Fig. 5A). Furthermore, adoptive transfer of LysMcre/Stat3flox/ macrophages resulted in a 1.8-fold increase in the number of infiltrating neutrophils. There was a trend toward increase in the number of infiltrating macrophages (1.6-fold increase) although it was not statistically significant (p = 0.15) (Fig. 5B). Thus, these data suggest that Stat3 in the peritoneal resident macrophages is responsible for the regulation of inflammation in this particular model.
|
|
| Discussion |
|---|
|
|
|---|
, MIP-2, KC, and MCP-1 relative to the leukopenic LysMcre/Stat3+/+ mice, suggesting that elevation of cytokines/chemokines was independent of infiltrating leukocytes. Adoptive transfer of LysMcre/Stat3flox/ resident macrophages into LysMcre/Stat3+/+ mice resulted in increases not only in the peritoneal level of cytokines/chemokines but also in the number of leukocyte infiltration in the peritoneum. Stat3 is a transcription factor mediating anti-inflammatory effects of IL-10 (9). Thus, resident macrophages, but not other cell types, appear to be an important target of IL-10 in this particular model.
Resident macrophages are regarded as sentinels in inflammation, as the cells are indigenous to tissues and readily recognize invading pathogens via pattern recognition receptors such as Toll-like receptors (17). Resident macrophages are capable of producing inflammatory cytokines/chemokines (18), thereby playing a central role in the recruitment of leukocytes (16, 19, 20, 21). A recent investigation provides clear evidence that peritoneal resident macrophages are essential in the orchestration of acute inflammation through macrophage-dependent cytokine/chemokines production (22). Meanwhile, as shown in this study and elsewhere (23), resident macrophages produce a potent anti-inflammatory cytokine IL-10. IL-10 inhibits inflammatory response in a variety of experimental models including peritonitis by down-regulating the production of inflammatory cytokines/chemokines (4, 24). Ajuebor et al. (25) have demonstrated a cytokine/chemokine inhibitory feedback loop based on IL-10 released from peritoneal resident macrophages. In our model of acute inflammation, IL-10 production in LysMcre/Stat3+/+ mice was parallel with TNF-
, MIP-2, KC, and MCP-1. Levels of TNF-
, MIP-2, KC, and MCP-1 in LysMcre/Stat3flox/ mice were significantly higher than those in the control littermates (Fig. 2). Although the peak IL-10 level in LysMcre/Stat3flox/ mice persisted, the IL-10 does not appear to mediate its anti-inflammatory effect in these mice, given that Stat3 is a key transcriptional factor mediating anti-inflammatory properties of IL-10 (9). The persistence of IL-10 level is possibly due to the enhanced production by resident peritoneal macrophages, given that IL-10 production by resident macrophages was augmented on stimulation with thioglycollate (Table II). The expression of IL-10 receptor 1 (IL-10R1) in LysMcre/Stat3flox/ resident macrophages was induced 21.9-fold more than control macrophages as assessed by gene expression analysis array (data not shown). Thus, resident macrophages trigger inflammation by producing inflammatory cytokines and chemokines, but the production of these mediators appears to be negatively regulated in the cells through a Stat3 signaling pathway that is most likely activated in response to IL-10 released by cells that include resident macrophages
Several mechanisms might contribute to the up-regulation of cytokines/chemokines in the absence of Stat3 in macrophages. Yu and Kone (27) have shown that Stat3 interacts physically with NF-
B, a ubiquitous transcription factor that controls the gene expression of many proinflammatory mediators (26), thereby inhibiting NF-
B-mediated trans-activation of the inducible NO synthase gene. Defective Stat3 activation in IL-10/ mice exhibited enhanced NF-
B activation (28). In addition, Stat3-deficient bone marrow cells displayed increased I
B phosphorylation and enhanced DNA-binding activity of NF-
B family members after stimulation with LPS (29). Thus, Stat3 appears to down-regulate cytokine/chemokine response in part by inhibiting NF-
B activation. Recently, cross-talk between transcription factors has become a commonly recognized mode of gene regulation. Therefore, interactions with different pathways also should be taken into consideration to further understand the biological significance at the molecular level.
Of interest were the findings that TNF-
and MIP-2 levels in LysMcre/Stat3+/+ mice harboring LysMcre/Stat3flox/ macrophages were lower than those in LysMcre/Stat3flox/ mice, whereas KC and MCP-1 levels were comparable between these groups (Figs. 4 and 5). This suggests that Stat3 in other cell types could contribute to the production of TNF-
and MIP-2. Mast cells are a rich source of cytokines/chemokines that include TNF-
and MIP-2 (30). In addition, peritoneal mesothelial cells are capable of producing TNF-
and MIP-2 (31, 32). Stat3 is ubiquitously expressed in a variety of cell types that include mast cells and peritoneal mesothelial cells (33, 34). Thus, Stat3 in these cell types may play a role in the production of TNF-
and MIP-2. Despite this, however, it is important that resident macrophages, but not other cell types, play a major role in down-regulating inflammatory response.
The recruitment of leukocytes after 24 h was not altered in LysMcre/Stat3flox/ mice. The numbers of infiltrating leukocytes at 24 and 48 h after thioglycollate injection were unchanged when LysMcre/Stat3flox/ resident macrophages or -infiltrating leukocytes were transferred into LysMcre/Stat3+/+ mice (data not shown). These results suggest that the late stage of inflammatory response (after 24 h) is functionally different from that in the early phase (before 8 h) in this experimental model. Judging from the production kinetics of cytokines/chemokines in this model, other cytokines/chemokines and their signaling pathways may be involved in the late phase. Further studies are necessary to explore the molecular basis.
We conclude that resident macrophages are important target of IL-10 in inflammation. The findings together with the primarily function of macrophages as triggering inflammation suggest that resident macrophages play a central role in an initial phase of inflammation. Excessive inflammation is harmful to the host. The present data highlight an inhibitory role of peritoneal resident macrophages in which Stat3 mediates the anti-inflammatory effects of IL-10, suggesting a new paradigm that the inflammatory response appears to be on an inhibitory basis by resident macrophages through a Stat3 signaling pathway.
| Acknowledgments |
|---|
| Disclosures |
|---|
|
|
|---|
| Footnotes |
|---|
1 This work was supported in part by grants from The Ministry of Education, Science, Sports and Culture, and The Ministry of Health and Welfare, Japan. ![]()
2 Address correspondence and reprint requests to Dr. Akihiro Matsukawa, Department of Pathology, Experimental Medicine, Graduate School of Medical Sciences, School of Medicine, Kumamoto University, 2-2-1, Honjo, Kumamoto 860-8556, Japan. E-mail address: mastu{at}kaiju.medic.kumamoto-u.ac.jp ![]()
3 Abbreviation used in this paper: KC, KC chemokine. ![]()
Received for publication March 8, 2005. Accepted for publication June 20, 2005.
| References |
|---|
|
|
|---|
, interleukin-1, and interleukin-8. Lab. Invest. 78:973.-985. [Medline]
, IL-1, IL-1 receptor antagonist, IL-8, and growth-related protein. Lab. Invest. 79:591.-600. [Medline]
, IL-1
, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis. Lab. Invest. 76:629.-638. [Medline]
B regulation in the immune system. Nat. Rev. Immunol. 2:725.-734. [Medline]
B p65 and iuducible nitric oxide synthase transrepression in mesangial cells. J. Am. Soc. Nephrol. 15:585.-591.
B recruitment to the IL-12p40 promoter in dendritic cells. Blood 105:689.-696. This article has been cited by other articles:
![]() |
C. Tang, Y. Liu, P. S. Kessler, A. M. Vaughan, and J. F. Oram The Macrophage Cholesterol Exporter ABCA1 Functions as an Anti-inflammatory Receptor J. Biol. Chem., November 20, 2009; 284(47): 32336 - 32343. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wanninger, M. Neumeier, J. Weigert, S. Bauer, T. S. Weiss, A. Schaffler, C. Krempl, C. Bleyl, C. Aslanidis, J. Scholmerich, et al. Adiponectin-stimulated CXCL8 release in primary human hepatocytes is regulated by ERK1/ERK2, p38 MAPK, NF-{kappa}B, and STAT3 signaling pathways Am J Physiol Gastrointest Liver Physiol, September 1, 2009; 297(3): G611 - G618. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Takahashi, C. Galligan, L. Tessarollo, and T. Yoshimura Monocyte Chemoattractant Protein-1 (MCP-1), Not MCP-3, Is the Primary Chemokine Required for Monocyte Recruitment in Mouse Peritonitis Induced with Thioglycollate or Zymosan A J. Immunol., September 1, 2009; 183(5): 3463 - 3471. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wan, J. M. C. Coppens, C. G. van Helden-Meeuwsen, P. J. M. Leenen, N. van Rooijen, N. A. Khan, R. C. M. Kiekens, R. Benner, and M. A. Versnel Chorionic gonadotropin alleviates thioglycollate-induced peritonitis by affecting macrophage function J. Leukoc. Biol., August 1, 2009; 86(2): 361 - 370. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Tangye, M. C. Cook, and D. A. Fulcher Insights into the Role of STAT3 in Human Lymphocyte Differentiation as Revealed by the Hyper-IgE Syndrome J. Immunol., January 1, 2009; 182(1): 21 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Fielding, R. M. McLoughlin, L. McLeod, C. S. Colmont, M. Najdovska, D. Grail, M. Ernst, S. A. Jones, N. Topley, and B. J. Jenkins IL-6 Regulates Neutrophil Trafficking during Acute Inflammation via STAT3 J. Immunol., August 1, 2008; 181(3): 2189 - 2195. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Mizgerd Acute Lower Respiratory Tract Infection N. Engl. J. Med., February 14, 2008; 358(7): 716 - 727. [Full Text] [PDF] |
||||
![]() |
K. Numata, M. Kubo, H. Watanabe, K. Takagi, H. Mizuta, S. Okada, S. L. Kunkel, T. Ito, and A. Matsukawa Overexpression of Suppressor of Cytokine Signaling-3 in T Cells Exacerbates Acetaminophen-Induced Hepatotoxicity J. Immunol., March 15, 2007; 178(6): 3777 - 3785. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Medina, C. J. de Almeida, E. Dew, J. Li, G. Bonuccelli, T. M. Williams, A. W. Cohen, R. G. Pestell, P. G. Frank, H. B. Tanowitz, et al. Caveolin-1-Deficient Mice Show Defects in Innate Immunity and Inflammatory Immune Response during Salmonella enterica Serovar Typhimurium Infection Infect. Immun., December 1, 2006; 74(12): 6665 - 6674. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Dimitriadis, C. Stoikos, Y.-L. Tan, and L. A. Salamonsen Interleukin 11 Signaling Components Signal Transducer and Activator of Transcription 3 (STAT3) and Suppressor of Cytokine Signaling 3 (SOCS3) Regulate Human Endometrial Stromal Cell Differentiation Endocrinology, August 1, 2006; 147(8): 3809 - 3817. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |